In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...
CellViva, a biopharmaceutical company pioneering the development of an innovative anti-VEGF therapy for pterygium—an unmet medical need in ophthalmology, is proud to announce the appointment of three ...